Solving neurodegeneration: common mechanisms and strategies for new treatments
Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Founda...
Saved in:
Published in | Molecular neurodegeneration Vol. 17; no. 1; pp. 23 - 29 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
21.03.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled “Solving Neurodegeneration”. This “think-tank” style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world’s leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss. |
---|---|
AbstractList | Abstract Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled “Solving Neurodegeneration”. This “think-tank” style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world’s leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss. Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled "Solving Neurodegeneration". This "think-tank" style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world's leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss.Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled "Solving Neurodegeneration". This "think-tank" style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world's leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss. Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled “Solving Neurodegeneration”. This “think-tank” style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world’s leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss. Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology or site of disease pathology. To address these mechanisms and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus Foundation, and the Melza M. and Frank Theodore Barr Foundation collaborated to bring together key opinion leaders and experts in the field of neurodegenerative disease for a virtual meeting titled "Solving Neurodegeneration". This "think-tank" style meeting focused on uncovering common mechanistic roots of neurodegenerative disease and promising targets for new treatments, catalyzed by the goal of finding new treatments for glaucoma, the world's leading cause of irreversible blindness and the common interest of the three hosting foundations. Glaucoma, which causes vision loss through degeneration of the optic nerve, likely shares early cellular and molecular events with other neurodegenerative diseases of the central nervous system. Here we discuss major areas of mechanistic overlap between neurodegenerative diseases of the central nervous system: neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions. We summarize important discussion points with emphasis on the research areas that are most innovative and promising in the treatment of neurodegeneration yet require further development. The research that is highlighted provides unique opportunities for collaboration that will lead to efforts in preventing neurodegeneration and ultimately vision loss. Keywords: Neurodegeneration, Alzheimer's Disease, Glaucoma, Parkinson's Disease, Huntington's Disease, Genetics, Metabolic stress, Neuro-regeneration, Neuro-replacement, Neurovascular coupling, Biomarker, Cell-replacement, Detection, Glia, Imaging, Model Systems, Organoids |
ArticleNumber | 23 |
Audience | Academic |
Author | Wareham, Lauren K. Subramanian, Preeti Torre, Anna La He, Zhigang Brunner, Thomas Liddelow, Shane A. Goldberg, Jeffrey L. Canto-Soler, M. Valeria Calkins, David J. Duan, Xin Flanagan, John G. Temple, Sally Wellington, Cheryl Bovenkamp, Diane E. Bu, Guojun Rossi, Sharyn Di Polo, Adriana Shekhar, Karthik Chan, David C. Benowitz, Larry I. Davis, Albert A. |
Author_xml | – sequence: 1 givenname: Lauren K. surname: Wareham fullname: Wareham, Lauren K. – sequence: 2 givenname: Shane A. surname: Liddelow fullname: Liddelow, Shane A. – sequence: 3 givenname: Sally surname: Temple fullname: Temple, Sally – sequence: 4 givenname: Larry I. surname: Benowitz fullname: Benowitz, Larry I. – sequence: 5 givenname: Adriana surname: Di Polo fullname: Di Polo, Adriana – sequence: 6 givenname: Cheryl surname: Wellington fullname: Wellington, Cheryl – sequence: 7 givenname: Jeffrey L. surname: Goldberg fullname: Goldberg, Jeffrey L. – sequence: 8 givenname: Zhigang surname: He fullname: He, Zhigang – sequence: 9 givenname: Xin surname: Duan fullname: Duan, Xin – sequence: 10 givenname: Guojun surname: Bu fullname: Bu, Guojun – sequence: 11 givenname: Albert A. surname: Davis fullname: Davis, Albert A. – sequence: 12 givenname: Karthik surname: Shekhar fullname: Shekhar, Karthik – sequence: 13 givenname: Anna La surname: Torre fullname: Torre, Anna La – sequence: 14 givenname: David C. surname: Chan fullname: Chan, David C. – sequence: 15 givenname: M. Valeria surname: Canto-Soler fullname: Canto-Soler, M. Valeria – sequence: 16 givenname: John G. surname: Flanagan fullname: Flanagan, John G. – sequence: 17 givenname: Preeti surname: Subramanian fullname: Subramanian, Preeti – sequence: 18 givenname: Sharyn surname: Rossi fullname: Rossi, Sharyn – sequence: 19 givenname: Thomas surname: Brunner fullname: Brunner, Thomas – sequence: 20 givenname: Diane E. surname: Bovenkamp fullname: Bovenkamp, Diane E. – sequence: 21 givenname: David J. orcidid: 0000-0002-8475-9959 surname: Calkins fullname: Calkins, David J. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35313950$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhS1URB_wB1igSGzYpPgRJzELpKriUamCBbC2_LhJPUrsYmeK-PfcmWnRTIWQF7bscz7r2OeUHMUUgZCXjJ4z1rdvCxOUNzXlvKZUblZPyAnrJK2Z4O3R3vqYnJayorTpUPiMHAspmFCSnpAv39J0F-JYRVjn5GGECNksIcV3lUvznGI1g7sxMZS5VCb6qix4DmOAUg0po-9XtWQwywxxKc_J08FMBV7cz2fkx8cP3y8_19dfP11dXlzXTrZiqa2wlDvbD3SQAEJR29vGQSNpw-zQcmNBeg-Cc9EoOQAM3tmWCeEZyL5z4oxc7bg-mZW-zWE2-bdOJujtRsqjNnkJbgLtBMZW3HvLWUM7aZSnbe-YBGR5xpH1fse6XdsZvMMc2UwH0MOTGG70mO50r4TslETAm3tATj_XUBY9h-JgmkyEtC6atw3rpeKsQ-nrR9JVWueIT4UqyQV-a7enGg0GCHFIeK_bQPVFq7pOqZYxVJ3_Q4XDwxwcVmUIuH9geLUf9G_ChzagoN8JXE6lZBi0C8u2DEgOk2ZUb4qnd8XTWDy9LZ7eWPkj6wP9P6Y_wL7aDw |
CitedBy_id | crossref_primary_10_1080_17460441_2023_2293158 crossref_primary_10_25259_ABP_42_2023 crossref_primary_10_3390_ijms25041991 crossref_primary_10_3390_futurepharmacol3040053 crossref_primary_10_1038_s41584_022_00905_1 crossref_primary_10_1055_a_2512_8928 crossref_primary_10_1016_j_neuroscience_2024_12_039 crossref_primary_10_1016_j_nbd_2022_105751 crossref_primary_10_1177_03946320241250293 crossref_primary_10_3389_fmed_2024_1432717 crossref_primary_10_1186_s40662_023_00359_w crossref_primary_10_1016_j_arr_2024_102254 crossref_primary_10_1002_mds_29883 crossref_primary_10_1186_s40478_024_01872_2 crossref_primary_10_3390_antiox13020191 crossref_primary_10_1146_annurev_genet_111523_102000 crossref_primary_10_2174_0929867330666230403085733 crossref_primary_10_1126_sciadv_adl5722 crossref_primary_10_1016_j_neubiorev_2022_104961 crossref_primary_10_1016_j_isci_2024_110006 crossref_primary_10_1007_s10266_025_01069_6 crossref_primary_10_1021_acschemneuro_4c00734 crossref_primary_10_1016_j_visres_2024_108461 crossref_primary_10_1038_s41467_024_52025_x crossref_primary_10_3390_antiox12091722 crossref_primary_10_1007_s13311_023_01355_7 crossref_primary_10_14336_AD_2024_1188 crossref_primary_10_21926_obm_neurobiol_2402223 crossref_primary_10_4103_1673_5374_387965 crossref_primary_10_1186_s13024_022_00571_7 crossref_primary_10_3390_nu15112564 crossref_primary_10_3389_fmed_2024_1468230 crossref_primary_10_3390_antiox12020518 crossref_primary_10_3389_fncel_2023_1281763 crossref_primary_10_1016_j_arr_2024_102482 crossref_primary_10_1167_iovs_65_8_15 crossref_primary_10_1007_s40291_023_00668_9 crossref_primary_10_21272_eumj_2023_11_1__1_13 crossref_primary_10_3390_cells13020188 crossref_primary_10_3390_molecules29246046 crossref_primary_10_1186_s12986_024_00800_4 crossref_primary_10_3389_fncel_2023_1257297 crossref_primary_10_4103_1673_5374_373702 crossref_primary_10_1016_j_nicl_2022_103300 crossref_primary_10_1016_j_preteyeres_2024_101261 crossref_primary_10_3389_fnins_2023_1228927 crossref_primary_10_1016_j_xcrm_2024_101839 crossref_primary_10_3390_microorganisms11071832 crossref_primary_10_1016_j_jare_2024_03_015 crossref_primary_10_5812_asjsm_149446 crossref_primary_10_3390_cells11223538 crossref_primary_10_3390_jcm13072102 crossref_primary_10_1016_j_drudis_2025_104289 crossref_primary_10_7759_cureus_61335 crossref_primary_10_1111_apha_14192 crossref_primary_10_1515_biol_2025_1069 crossref_primary_10_3390_ijms241612555 crossref_primary_10_3390_molecules27238448 crossref_primary_10_1038_s41593_023_01415_3 crossref_primary_10_3390_ijms25189994 crossref_primary_10_1186_s13024_024_00704_0 crossref_primary_10_1016_j_jtos_2023_05_009 crossref_primary_10_1038_s41593_024_01663_x crossref_primary_10_1002_ana_26580 crossref_primary_10_1523_ENEURO_0459_22_2023 crossref_primary_10_4103_1673_5374_380876 crossref_primary_10_17116_patol20228405159 crossref_primary_10_3389_fncel_2023_1205261 crossref_primary_10_3390_antiox13091062 crossref_primary_10_3390_ijms24032985 crossref_primary_10_1016_j_joi_2024_101617 crossref_primary_10_3390_pharmaceutics15051467 crossref_primary_10_3897_pharmacia_71_e123549 crossref_primary_10_3389_fphar_2022_926123 crossref_primary_10_1016_S0140_6736_23_01289_8 crossref_primary_10_3389_fneur_2022_929290 crossref_primary_10_1007_s13205_024_04158_5 crossref_primary_10_1016_j_abb_2025_110356 crossref_primary_10_1016_j_compbiolchem_2025_108415 crossref_primary_10_3389_fnins_2023_1244679 crossref_primary_10_1016_j_molmed_2023_08_005 crossref_primary_10_2174_0122106812320650241015153325 crossref_primary_10_3389_facou_2023_1269867 crossref_primary_10_1364_BOE_505395 crossref_primary_10_4103_1673_5374_355765 crossref_primary_10_3389_fnagi_2024_1485657 crossref_primary_10_1016_j_brainres_2025_149531 crossref_primary_10_3390_cells12182330 crossref_primary_10_1016_j_hermed_2023_100775 crossref_primary_10_1007_s11154_024_09920_x crossref_primary_10_1016_j_brainres_2024_149352 crossref_primary_10_1186_s40580_024_00426_5 crossref_primary_10_3390_antiox11061199 crossref_primary_10_1007_s10822_025_00588_2 crossref_primary_10_1097_MD_0000000000038455 crossref_primary_10_3389_fmolb_2025_1506961 crossref_primary_10_1007_s43440_024_00610_8 crossref_primary_10_1016_j_pbiomolbio_2024_12_004 crossref_primary_10_1016_j_jff_2025_106676 crossref_primary_10_1186_s12944_024_02337_0 crossref_primary_10_1007_s12265_023_10445_y crossref_primary_10_1038_s41467_023_44307_7 crossref_primary_10_3389_fnmol_2024_1414886 crossref_primary_10_1016_j_preteyeres_2023_101217 crossref_primary_10_1016_j_metop_2023_100233 crossref_primary_10_1016_j_jenvman_2024_120429 crossref_primary_10_1002_adfm_202313806 crossref_primary_10_1007_s12011_023_03778_x crossref_primary_10_1097_IJG_0000000000002353 crossref_primary_10_1016_j_rechem_2024_101813 crossref_primary_10_1111_acel_13737 crossref_primary_10_1186_s13024_024_00775_z crossref_primary_10_3390_cells11203241 crossref_primary_10_1016_j_arr_2024_102357 crossref_primary_10_3389_fncel_2024_1427525 crossref_primary_10_2174_1570159X2214240709123555 crossref_primary_10_3390_molecules27227816 crossref_primary_10_3390_ph17060741 crossref_primary_10_3390_app142412029 crossref_primary_10_3390_bioengineering12030287 crossref_primary_10_1016_j_jneuroim_2024_578363 crossref_primary_10_1039_D3BM02044D crossref_primary_10_1007_s12035_022_03179_6 crossref_primary_10_1007_s10517_024_06218_5 crossref_primary_10_1016_j_nbd_2024_106631 crossref_primary_10_3390_proteomes12010007 crossref_primary_10_47093_2218_7332_2024_15_1_20_35 crossref_primary_10_3390_ijms25010365 crossref_primary_10_1007_s12035_024_04462_4 crossref_primary_10_3390_biom12111676 crossref_primary_10_4103_1673_5374_360169 crossref_primary_10_3390_pharmaceutics15051370 crossref_primary_10_3390_ijms23158180 crossref_primary_10_3390_biom12111671 crossref_primary_10_3390_life12091439 |
Cites_doi | 10.3389/fneur.2021.681326 10.1093/brain/aww015 10.1001/jamaophthalmol.2021.2440 10.1016/j.nbd.2019.03.021 10.1016/S0161-6420(97)30005-0 10.1063/5.0035610 10.1101/cshperspect.a017269 10.1212/WNL.0000000000003397 10.2174/156720511795745348 10.1016/0304-3940(96)12760-9 10.1038/s41591-018-0051-5 10.1038/s41593-020-0599-5 10.1016/S0140-6736(10)61156-7 10.1111/jnc.14273 10.1016/j.preteyeres.2020.100938 10.1016/j.brainres.2018.12.030 10.1161/CIRCRESAHA.118.313400 10.1016/j.preteyeres.2020.100916 10.1038/ng1197-263 10.1113/jphysiol.1890.sp000321 10.1186/s13024-020-00418-z 10.1056/NEJMsa1204629 10.1016/j.survophthal.2017.06.007 10.1212/WNL.38.8.1285 10.1038/nature24016 10.1111/1440-1681.12758 10.1016/S0896-6273(00)80086-0 10.1016/j.cell.2005.02.001 10.1016/j.neulet.2017.11.027 10.1126/science.abk0575 10.1016/j.celrep.2020.108271 10.1016/j.neuron.2020.09.016 10.1038/nn.4340 10.1016/j.nbd.2020.104953 10.1016/0039-6257(89)90010-6 10.1097/NEN.0b013e31820376cc 10.1136/bjo.54.7.461 10.1016/j.mad.2021.111438 10.1016/S1350-9462(01)00005-2 10.1146/annurev-neuro-070918-050154 10.1038/s41596-018-0029-2 10.1038/s41598-020-71460-6 10.1016/j.yfrne.2019.100804 10.1038/s41591-021-01382-x 10.1016/j.bbalip.2021.158980 10.1016/j.neuron.2020.05.014 10.1016/j.preteyeres.2021.100953 10.3233/JAD-141659 10.3389/fimmu.2018.01056 10.1016/j.yfrne.2020.100850 10.1007/s00415-010-5863-2 10.1016/j.exer.2015.02.011 10.1111/acel.12589 10.1126/science.aay2720 10.1371/journal.pone.0057557 10.1002/alz.12097 10.3389/fnene.2010.00005 10.1167/iovs.09-3947 10.1161/STROKEAHA.107.493262 10.1038/nature11283 10.1523/JNEUROSCI.1447-08.2008 10.1126/science.abb8575 10.1016/j.expneurol.2015.12.015 10.1007/s11357-020-00252-7 10.1111/vop.12858 10.1097/00061198-200408000-00013 10.1089/ars.2020.8075 10.1002/ana.24135 10.1038/nbt.4127 10.1016/j.brainres.2018.08.006 10.3233/JAD-170777 10.1016/j.ncl.2014.09.010 10.1038/s41582-021-00483-y 10.1523/JNEUROSCI.1860-14.2014 10.3390/biomedicines8120591 10.1038/s41467-019-14279-8 10.3389/fnins.2019.00521 10.1038/s41586-020-2589-x 10.1016/j.arcmed.2017.08.002 10.1001/jamaneurol.2019.0765 10.1016/j.neurobiolaging.2007.11.014 10.1016/j.exer.2009.02.003 10.1002/jnr.24256 10.1007/BF00308809 10.1016/j.tips.2020.09.011 10.1186/s13195-019-0479-y 10.1016/j.neuron.2015.02.017 10.1212/WNL.42.3.631 10.1093/braincomms/fcz035 10.1038/s41591-020-0886-4 10.1016/j.celrep.2020.107776 10.1016/j.jpsychires.2020.07.015 10.3791/57122 10.1016/j.mito.2017.08.014 10.1167/iovs.61.8.3 10.1093/hmg/ddu277 10.1038/ncomms10472 10.1002/ana.20694 10.1126/science.1134108 10.1002/cpim.70 10.1186/alzrt269 10.3389/fimmu.2018.00586 10.1006/nbdi.2002.0483 10.1038/s41380-020-0721-9 10.3389/fneur.2019.00122 10.3233/ADR-210283 10.7554/eLife.29595 10.1038/s41598-020-66092-9 10.1016/j.celrep.2017.12.039 10.1172/JCI77398 10.1371/journal.pone.0067094 10.1038/s41467-018-05681-9 10.3390/pharmaceutics13060865 10.3390/biomedicines9050524 10.3389/fnins.2021.639140 10.1523/JNEUROSCI.23-06-02284.2003 10.1016/j.exger.2016.11.004 10.1111/aos.13983 10.1073/pnas.1423221112 10.1038/33416 10.1073/pnas.1800165115 10.1016/j.preteyeres.2020.100880 10.1146/annurev-pathmechdis-012419-032711 10.1002/dvdy.24672 10.1038/nrn1824 10.1002/jnr.1104 10.1101/2021.10.21.465277 10.1016/j.preteyeres.2019.100799 10.1002/ana.25246 10.1016/S0039-6257(99)00018-1 10.1002/glia.20404 10.1126/scitranslmed.aay1809 10.1007/s10571-020-00965-5 10.1056/NEJMoa1211103 10.1056/NEJMoa1211851 10.1016/j.neuron.2020.09.029 10.3389/fcell.2020.00452 10.1136/jmg.31.4.280 10.1007/s00417-011-1842-2 10.1073/pnas.1525528113 10.1038/s41467-020-17514-9 10.1146/annurev-vision-022720-094953 10.1016/j.jalz.2014.10.008 10.1016/0039-6257(80)90123-X 10.1016/j.stemcr.2020.12.001 10.1016/j.neulet.2010.06.006 10.1007/s13311-011-0047-z 10.1038/s41586-020-2709-7 10.1007/s00441-013-1666-y 10.3389/fimmu.2020.00065 10.1371/journal.pone.0134750 10.3389/fnut.2021.669846 10.1086/319522 10.1083/jcb.202102136 10.1016/j.nicl.2021.102718 10.1186/s13550-020-00653-x 10.1038/s41582-020-0333-7 10.1242/dev.146290 10.1002/mds.28242 10.3389/fneur.2021.651639 10.1523/JNEUROSCI.2468-15.2015 10.1093/cercor/bhs222 10.1074/jbc.R800019200 10.1001/archopht.1979.01020010136007 10.1126/scitranslmed.abc9375 10.1016/S1474-4422(16)00070-3 10.1111/j.1749-6632.2000.tb06651.x 10.1016/j.immuni.2021.01.013 10.1073/pnas.0907085106 10.1001/archopht.117.8.1050 10.1016/j.ophtha.2014.05.013 10.1038/nn.2946 10.1016/j.jalz.2011.03.005 10.1523/JNEUROSCI.3200-08.2008 10.1016/j.tibs.2020.11.007 10.1016/j.jneumeth.2021.109281 10.1126/scitranslmed.aaw3210 10.3390/cells10050994 10.1038/s41582-019-0244-7 10.1002/ana.24969 10.1093/brain/awt188 10.1007/s00417-019-04382-3 10.3389/fnagi.2018.00203 10.1073/pnas.2009425117 10.1038/s41433-019-0632-7 10.1002/ana.24182 10.1001/jamaophthalmol.2018.3556 10.1002/(SICI)1099-1166(199809)13:9<625::AID-GPS835>3.0.CO;2-2 10.1038/nrg3461 10.1111/j.1755-3768.2011.02175.x 10.1371/journal.pmed.1002487 10.1073/pnas.2110329119 10.1186/s13024-021-00467-y 10.1038/s41593-020-0687-6 10.3390/biom11040581 10.1136/bjophthalmol-2017-310476 10.1371/journal.pbio.1000298 10.1523/JNEUROSCI.1747-16.2016 10.15252/emmm.202114781 10.1186/s13024-021-00424-9 10.1146/annurev-vision-121219-081855 10.1038/nrdp.2017.13 10.1042/BIO20200063 10.1038/s41591-019-0611-3 10.1167/iovs.13-12046 10.1002/ana.25682 10.1007/BF00946937 10.1038/s41591-020-0938-9 10.1038/nature19323 10.3389/fphar.2021.643254 10.1007/s40142-019-0158-0 10.1101/2021.07.15.452509 10.1038/nn.2923 10.3389/fcell.2020.00328 10.1038/s41586-020-03116-4 10.1016/j.cell.2014.12.019 10.1016/j.cell.2020.10.029 10.1016/j.exer.2010.08.016 10.1006/exnr.2001.7822 10.1016/j.ajo.2004.04.045 10.1126/science.1957169 10.1136/bmj.n1682 10.1073/pnas.1509879112 10.1002/cne.22516 10.1080/15548627.2017.1291114 10.1016/j.devcel.2020.04.009 10.1016/j.exer.2010.09.005 10.3109/08820538.2015.1114845 10.1038/nn1701 10.1038/nature21029 10.1001/jamaneurol.2021.3180 10.1016/j.exer.2017.02.014 10.1016/j.mcn.2018.12.001 10.1136/bjo.53.11.721 10.1002/acn3.51158 10.3389/fnins.2020.00577 10.1038/nature09613 10.1523/JNEUROSCI.4340-10.2010 10.1126/science.aal0092 10.1016/j.neuron.2019.11.006 10.1172/JCI44646 10.1016/j.preteyeres.2020.100875 10.1038/s41582-020-00435-y 10.3390/ijms22094956 10.3390/cells7060060 10.1016/j.neuron.2021.03.024 10.1126/scitranslmed.aay3069 10.1016/j.neuron.2015.03.060 10.1016/j.neuron.2011.07.022 10.1186/s13195-020-00612-7 10.1096/fj.201601084R 10.1186/s13024-020-00376-6 10.1016/j.abb.2021.108815 10.1001/archopht.1968.00980050698002 10.1016/j.jneumeth.2020.108623 10.1038/d41586-021-01546-2 10.1016/j.psyneuen.2009.02.009 10.3389/fimmu.2018.01287 10.1016/j.cell.2013.05.039 10.1073/pnas.1107402108 10.3390/cells9112415 10.1038/ni.3666 10.1016/j.mcna.2018.10.009 10.1167/iovs.04-1347 10.1523/JNEUROSCI.20-12-04615.2000 10.1016/S0079-6123(08)01125-4 10.1016/0140-6736(93)91705-Q 10.1016/S0161-6420(96)30572-1 10.1038/nrn1387 10.1016/j.jalz.2015.12.003 10.1038/ncomms5047 10.1016/j.trci.2018.06.014 10.1016/j.neuron.2017.07.030 10.1155/2021/4581909 10.1067/mcp.2001.113989 10.1083/jcb.200508072 10.1038/s41563-020-00804-4 10.1167/iovs.18-25837 10.1016/j.survophthal.2017.09.010 10.3233/ADR-200171 10.1016/j.exer.2019.107900 10.3390/cells9081759 10.1016/j.nbd.2014.07.016 10.1097/00006324-199908000-00022 10.1016/j.neuron.2015.11.013 10.1101/cshperspect.a009258 10.1016/j.mad.2021.111473 10.1186/s13024-021-00452-5 10.1167/iovs.03-0587 10.1016/j.cell.2021.07.003 10.3390/biology8020031 10.1016/j.exer.2017.02.006 10.1001/jamaneurol.2020.3311 10.1016/j.preteyeres.2021.100976 10.1212/01.WNL.0000063311.58879.01 10.1186/s12974-019-1399-2 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13024-022-00524-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (New) ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1750-1326 |
EndPage | 29 |
ExternalDocumentID | oai_doaj_org_article_c304792ddb214075a9d068c15e1e5d12 PMC8935795 A697799611 35313950 10_1186_s13024_022_00524_0 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: NEI NIH HHS grantid: P30 EY026877 – fundername: NIA NIH HHS grantid: U19 AG069701 – fundername: NICHD NIH HHS grantid: P50 HD105351 – fundername: NEI NIH HHS grantid: R01 EY030218 – fundername: NEI NIH HHS grantid: R01 EY030138 – fundername: NIA NIH HHS grantid: RF1 AG057181 – fundername: NIGMS NIH HHS grantid: R35 GM127147 – fundername: NINDS NIH HHS grantid: R01 NS123912 – fundername: NIA NIH HHS grantid: RF1 AG046205 – fundername: NEI NIH HHS grantid: R01 EY026942 – fundername: ; grantid: Melza M. and Frank Theodore Barr Foundation – fundername: ; grantid: Glaucoma Research Foundation – fundername: ; grantid: BrightFocus Foundation |
GroupedDBID | --- 0R~ 123 29M 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE IAO IHR INH INR IPY ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-b3b02cb8f0f5ee390b8b4ce45041bf62abe5dde3223495feefdcb6133d1e587c3 |
IEDL.DBID | M48 |
ISSN | 1750-1326 |
IngestDate | Wed Aug 27 00:12:07 EDT 2025 Thu Aug 21 18:40:36 EDT 2025 Fri Jul 11 09:48:48 EDT 2025 Sat Jul 26 01:18:39 EDT 2025 Tue Jun 17 21:41:53 EDT 2025 Tue Jun 10 20:41:21 EDT 2025 Thu Apr 03 07:00:57 EDT 2025 Tue Jul 01 01:59:05 EDT 2025 Thu Apr 24 23:01:26 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Glaucoma Model Systems Biomarker Huntington’s Disease Alzheimer’s Disease Neuro-regeneration Neuro-replacement Organoids Neurodegeneration Imaging Cell-replacement Genetics Parkinson’s Disease Detection Glia Metabolic stress Neurovascular coupling |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-b3b02cb8f0f5ee390b8b4ce45041bf62abe5dde3223495feefdcb6133d1e587c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-8475-9959 |
OpenAccessLink | https://www.proquest.com/docview/2652318677?pq-origsite=%requestingapplication% |
PMID | 35313950 |
PQID | 2652318677 |
PQPubID | 55149 |
PageCount | 29 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c304792ddb214075a9d068c15e1e5d12 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8935795 proquest_miscellaneous_2641859217 proquest_journals_2652318677 gale_infotracmisc_A697799611 gale_infotracacademiconefile_A697799611 pubmed_primary_35313950 crossref_citationtrail_10_1186_s13024_022_00524_0 crossref_primary_10_1186_s13024_022_00524_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-21 |
PublicationDateYYYYMMDD | 2022-03-21 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-21 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Molecular neurodegeneration |
PublicationTitleAlternate | Mol Neurodegener |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | B Liu (524_CR37) 2018; 63 AB Malpartida (524_CR118) 2021; 46 524_CR285 MM Boisvert (524_CR49) 2018; 22 JW Lewcock (524_CR59) 2020; 108 J Qu (524_CR80) 2013; 8 AL Kornzweig (524_CR161) 1968; 80 CS Roy (524_CR134) 1890; 11 524_CR162 D Marcos-Perez (524_CR53) 2018; 9 R Guerreiro (524_CR255) 2013; 368 N El Seblani (524_CR263) 2020; 335 N Mattsson (524_CR210) 2019; 76 C Barro (524_CR197) 2021; 361 AG Hvozda Arana (524_CR128) 2021; 701 R Thangavel (524_CR61) 2018; 61 D Fischer (524_CR268) 2001; 172 MB Wax (524_CR95) 2011; 93 J Zhang (524_CR273) 2020; 588 I Livne-Bar (524_CR305) 2017; 127 C Lopez-Otin (524_CR50) 2013; 153 E McDade (524_CR262) 2021; 16 I Driscoll (524_CR296) 2011; 8 O Gureje (524_CR65) 2006; 59 JN Duarte (524_CR107) 2021; 2021 524_CR172 IA Sigal (524_CR29) 2009; 88 524_CR173 Q Qin (524_CR258) 2021; 195 ER Tamm (524_CR30) 2017; 157 BR Price (524_CR145) 2018; 144 S Tarantini (524_CR14) 2017; 94 CJ Bohlen (524_CR239) 2019; 125 GM McKhann (524_CR4) 2011; 7 CE Riva (524_CR156) 1986; 27 KR Bales (524_CR168) 1997; 17 AA Mansour (524_CR250) 2018; 36 IM Rea (524_CR52) 2018; 9 Y Lu (524_CR222) 2010; 480 C Barth (524_CR177) 2020; 58 P Tammineni (524_CR124) 2017; 13 EA Winkler (524_CR137) 2011; 14 I Bodis-Wollner (524_CR220) 2014; 75 AP Mecca (524_CR209) 2020; 16 RM Sappington (524_CR232) 2010; 51 524_CR148 J Cummings (524_CR287) 2021; 16 524_CR144 S Palmqvist (524_CR200) 2016; 139 SP Yun (524_CR74) 2018; 24 MR Hernandez (524_CR160) 2008; 173 MC Tierney (524_CR180) 2009; 34 A Qassim (524_CR188) 2020; 42 G Biomarkers Definitions Working (524_CR195) 2001; 69 I Broce (524_CR260) 2018; 15 E Marziani (524_CR223) 2013; 54 H Braak (524_CR8) 1991; 82 F Leger (524_CR218) 2011; 70 524_CR27 W Shi (524_CR73) 2003; 24 KA Guttenplan (524_CR105) 2020; 31 C Iadecola (524_CR15) 2018; 123 524_CR22 524_CR139 Y Yin (524_CR100) 2003; 23 AS Rambold (524_CR109) 2011; 108 Q Wang (524_CR123) 2019; 127 CM Weber (524_CR184) 2021; 5 524_CR279 G Pattabiraman (524_CR47) 2017; 16 G Lalli (524_CR292) 2021; 13 RN Weinreb (524_CR26) 2004; 138 CY Cheung (524_CR224) 2015; 45 524_CR276 B Barrette (524_CR99) 2008; 28 MA Marin (524_CR264) 2016; 36 LS Robison (524_CR185) 2019; 1710 Y Hou (524_CR38) 2019; 15 J Tulloch (524_CR63) 2018; 1698 Y Yin (524_CR102) 2009; 106 C Peng (524_CR221) 2020; 16 I Marques-Aleixo (524_CR40) 2021; 34 524_CR18 T Jonsson (524_CR256) 2013; 368 524_CR19 SC Jin (524_CR257) 2014; 23 PR Williams (524_CR254) 2020; 6 G Garhofer (524_CR155) 2005; 46 AM Miltner (524_CR277) 2019; 248 GR Howell (524_CR82) 2014; 71 JW Blanchard (524_CR163) 2020; 26 JS Perlmutter (524_CR291) 2021; 372 JA Holbrook (524_CR44) 2021; 12 Y Lu (524_CR284) 2020; 53 NM Tran (524_CR280) 2019; 104 Á Fehér (524_CR302) 2018; 664 E Garreta (524_CR252) 2021; 20 524_CR241 K Nitta (524_CR93) 2019; 257 O Hansson (524_CR196) 2021; 27 A Liesz (524_CR11) 2019; 365 AH Neufeld (524_CR84) 1999; 117 KY Zhang (524_CR278) 2021; 16 LH Chen (524_CR167) 2020; 129 B Sinyor (524_CR57) 2020; 4 EM Valente (524_CR116) 2001; 68 M Lawlor (524_CR31) 2018; 63 SS Hayreh (524_CR150) 2001; 20 JH Lim (524_CR267) 2016; 19 PA Williams (524_CR41) 2017; 157 524_CR117 524_CR238 E Lentini (524_CR175) 2013; 23 524_CR2 CC Liu (524_CR300) 2021; 13 P Venugopalan (524_CR275) 2016; 7 T Kurimoto (524_CR103) 2010; 30 NC Cullen (524_CR207) 2020; 7 M Xiying (524_CR67) 2017; 48 S Leon (524_CR269) 2000; 20 524_CR251 E Bellou (524_CR165) 2020; 142 RA Harper (524_CR193) 1999; 76 M Bulut (524_CR226) 2018; 102 G Swarup (524_CR130) 2018; 9 C Franceschi (524_CR46) 2000; 908 K Gugleta (524_CR159) 2012; 250 R Sims (524_CR261) 2020; 23 J Sevigny (524_CR289) 2016; 537 M Scholl (524_CR202) 2019; 97 BE O’Bryhim (524_CR227) 2018; 136 JY Shin (524_CR272) 2005; 171 S Fereshetian (524_CR304) 2021; 5 R Businaro (524_CR39) 2021; 8 S Biswas (524_CR234) 2019; 97 JK Sterling (524_CR75) 2020; 33 M Seto (524_CR293) 2021; 16 PV Arriagada (524_CR7) 1992; 42 S Mullin (524_CR17) 2015; 33 524_CR216 RT Han (524_CR45) 2021; 54 524_CR217 524_CR113 N Solovieff (524_CR259) 2013; 14 G Beykin (524_CR194) 2021; 80 CF Burgoyne (524_CR28) 2011; 93 S Walsh (524_CR288) 2021; 374 SH MacGowan (524_CR182) 1998; 13 ML Cooper (524_CR106) 2020; 117 524_CR110 524_CR231 G Thinakaran (524_CR9) 2008; 283 Y Zhang (524_CR121) 2016; 89 SW Siegner (524_CR89) 1996; 103 R Hage (524_CR133) 2021; 12 YA Ito (524_CR129) 2017; 36 SS Dewundara (524_CR186) 2016; 31 WY Wang (524_CR55) 2015; 3 W Poewe (524_CR16) 2017; 3 MA Busche (524_CR303) 2020; 23 AM Komaromy (524_CR191) 2021; 24 YC Tham (524_CR23) 2014; 121 B Olsson (524_CR199) 2016; 15 JL Cummings (524_CR230) 2014; 6 LM Sanmarco (524_CR274) 2021; 590 Y Tang (524_CR51) 2017; 44 524_CR201 L Barbar (524_CR242) 2020; 107 A Bosco (524_CR78) 2011; 519 JR Tribble (524_CR125) 2019; 1 DM O’Hara (524_CR119) 2020; 14 S Jiang (524_CR86) 2020; 11 A Slanzi (524_CR228) 2020; 8 S Belin (524_CR266) 2015; 86 SS Hayreh (524_CR151) 1969; 53 D Huang (524_CR214) 1991; 254 H Resch (524_CR90) 2011; 89 JW Kinney (524_CR56) 2018; 4 D Attwell (524_CR138) 2010; 468 PA Williams (524_CR126) 2017; 355 A Atri (524_CR286) 2019; 103 DP Narendra (524_CR114) 2010; 8 524_CR83 X Wei (524_CR76) 2019; 97 K Sugiyama (524_CR91) 1997; 104 RZ Levene (524_CR25) 1980; 24 524_CR215 SS Hayreh (524_CR149) 1999; 43 L Liu (524_CR112) 2015; 160 B Engelhardt (524_CR143) 2017; 18 W Yan (524_CR283) 2020; 10 LM Garcia-Segura (524_CR183) 2006; 54 H Choquet (524_CR189) 2020; 34 AM Fagan (524_CR169) 2002; 9 B Fortune (524_CR36) 2019; 60 E Caggiu (524_CR71) 2019; 10 G Garhofer (524_CR154) 2003; 44 S Giatti (524_CR176) 2020; 56 C Czakó (524_CR10) 2020; 42 H Wesseling (524_CR204) 2020; 183 Y Shi (524_CR170) 2017; 549 T Jonsson (524_CR297) 2012; 488 JB Toledo (524_CR12) 2013; 136 JC Downs (524_CR33) 2015; 133 524_CR77 524_CR205 X Zhong (524_CR247) 2014; 5 KT Baldwin (524_CR270) 2015; 112 GR Howell (524_CR79) 2011; 121 KR Bowles (524_CR246) 2021; 184 RS Balaban (524_CR111) 2005; 120 MD Hurd (524_CR1) 2013; 368 X Duan (524_CR281) 2015; 85 MP Vitek (524_CR62) 2009; 30 EM Reiman (524_CR301) 2020; 11 DA Levine (524_CR146) 2011; 8 W Wang (524_CR122) 2020; 15 V Del Dotto (524_CR131) 2021; 12 EM Rhea (524_CR140) 2019; 13 TJ Montine (524_CR294) 2019; 11 HM Snyder (524_CR147) 2015; 11 MC Kiernan (524_CR20) 2011; 377 M Koronyo-Hamaoui (524_CR219) 2011; 54 JF Arboleda-Velasquez (524_CR299) 2019; 25 J Poirier (524_CR60) 1993; 342 JD Rothstein (524_CR271) 1996; 16 RZ Levene (524_CR24) 1980; 12 SM Drance (524_CR94) 1989; 33 SA Liddelow (524_CR104) 2017; 541 S Velasco (524_CR244) 2020; 43 TJ Hohman (524_CR295) 2016; 87 PL McGeer (524_CR72) 1988; 38 MC Power (524_CR13) 2018; 84 S Manne (524_CR206) 2020; 35 S Gauthier (524_CR229) 2016; 12 KA Guttenplan (524_CR70) 2020; 11 RJ Oostra (524_CR132) 1994; 31 JA Chowen (524_CR174) 2021; 196 PNE Young (524_CR198) 2020; 12 KB VanderWall (524_CR282) 2020; 10 H Chen (524_CR98) 2018; 9 G Garhofer (524_CR158) 2004; 13 OM Siggs (524_CR192) 2021; 139 P Giannakopoulos (524_CR6) 2003; 60 MS Kottler (524_CR88) 1976; 11 S Dujardin (524_CR5) 2020; 26 ML Bennett (524_CR240) 2016; 113 JW Gargano (524_CR179) 2008; 39 H Martiskainen (524_CR298) 2017; 82 A Mullard (524_CR290) 2021; 594 BC Trumble (524_CR66) 2017; 31 Y Zhang (524_CR120) 2014; 34 L Alarcon-Martinez (524_CR153) 2020; 585 G Natale (524_CR141) 2021; 15 L Ibanez (524_CR166) 2019; 7 F Leng (524_CR3) 2021; 17 L Gaetani (524_CR211) 2020; 41 OW Gramlich (524_CR96) 2013; 8 C Iadecola (524_CR136) 2004; 5 524_CR42 524_CR43 MN Vergara (524_CR248) 2017; 144 NJ Abbott (524_CR142) 2006; 7 R Seitz (524_CR81) 2013; 353 D Matuskey (524_CR208) 2020; 87 H Zetterberg (524_CR253) 2021; 26 J Wang (524_CR265) 2020; 108 P Hasel (524_CR54) 2021; 17 524_CR34 MA Margeta (524_CR68) 2020; 61 R Susanna (524_CR92) 1979; 97 S Schnichels (524_CR236) 2021; 81 C Iadecola (524_CR135) 2017; 96 J Robert (524_CR249) 2020; 15 MB Wax (524_CR97) 2008; 28 AI Arroba (524_CR87) 2018; 10 K Nordengen (524_CR212) 2019; 16 524_CR187 LC Foo (524_CR237) 2011; 71 L Yuan (524_CR85) 2001; 64 A Altmann (524_CR178) 2014; 75 W Morozumi (524_CR35) 2020; 191 T Kitada (524_CR115) 1998; 392 Y Yin (524_CR101) 2006; 9 SS Hayreh (524_CR152) 1970; 54 M Neumann (524_CR21) 2006; 314 M Axelsson (524_CR213) 2011; 258 Y Takihara (524_CR127) 2015; 112 IH Pang (524_CR233) 2020; 75 CM Bell (524_CR245) 2020; 6 MJ Pontecorvo (524_CR203) 2020; 10 DC Chan (524_CR108) 2020; 15 A Sierksma (524_CR164) 2020; 370 524_CR190 G Coppola (524_CR225) 2015; 10 O Levy (524_CR69) 2015; 35 LK Wareham (524_CR32) 2020; 8 CE Riva (524_CR157) 1997; 235 LE Clarke (524_CR48) 2018; 115 CA Singer (524_CR181) 1996; 212 LI Benowitz (524_CR235) 2017; 287 M Prinz (524_CR58) 2011; 14 J Qiu (524_CR243) 2018; 13 AB Chai (524_CR64) 2021; 1866 C Wang (524_CR171) 2021; 109 |
References_xml | – volume: 12 start-page: 681326 year: 2021 ident: 524_CR131 publication-title: Front Neurol doi: 10.3389/fneur.2021.681326 – volume: 139 start-page: 1226 year: 2016 ident: 524_CR200 publication-title: Brain doi: 10.1093/brain/aww015 – volume: 139 start-page: 1023 year: 2021 ident: 524_CR192 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2021.2440 – volume: 127 start-page: 410 year: 2019 ident: 524_CR123 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2019.03.021 – volume: 104 start-page: 1926 year: 1997 ident: 524_CR91 publication-title: Ophthalmology doi: 10.1016/S0161-6420(97)30005-0 – volume: 5 start-page: 011509 year: 2021 ident: 524_CR184 publication-title: APL Bioeng doi: 10.1063/5.0035610 – ident: 524_CR83 doi: 10.1101/cshperspect.a017269 – volume: 87 start-page: 2443 year: 2016 ident: 524_CR295 publication-title: Neurology doi: 10.1212/WNL.0000000000003397 – volume: 8 start-page: 330 year: 2011 ident: 524_CR296 publication-title: Curr Alzheimer Res doi: 10.2174/156720511795745348 – volume: 212 start-page: 13 year: 1996 ident: 524_CR181 publication-title: Neurosci Lett doi: 10.1016/0304-3940(96)12760-9 – volume: 24 start-page: 931 year: 2018 ident: 524_CR74 publication-title: Nat Med doi: 10.1038/s41591-018-0051-5 – volume: 23 start-page: 311 year: 2020 ident: 524_CR261 publication-title: Nat Neurosci doi: 10.1038/s41593-020-0599-5 – volume: 377 start-page: 942 year: 2011 ident: 524_CR20 publication-title: Lancet doi: 10.1016/S0140-6736(10)61156-7 – volume: 144 start-page: 644 year: 2018 ident: 524_CR145 publication-title: J Neurochem doi: 10.1111/jnc.14273 – ident: 524_CR217 doi: 10.1016/j.preteyeres.2020.100938 – volume: 1710 start-page: 43 year: 2019 ident: 524_CR185 publication-title: Brain Res doi: 10.1016/j.brainres.2018.12.030 – volume: 123 start-page: 406 year: 2018 ident: 524_CR15 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.313400 – ident: 524_CR77 doi: 10.1016/j.preteyeres.2020.100916 – volume: 17 start-page: 263 year: 1997 ident: 524_CR168 publication-title: Nat Genet doi: 10.1038/ng1197-263 – volume: 11 start-page: 85 year: 1890 ident: 524_CR134 publication-title: J Physiol doi: 10.1113/jphysiol.1890.sp000321 – volume: 15 start-page: 70 year: 2020 ident: 524_CR249 publication-title: Mol neurodegeneration doi: 10.1186/s13024-020-00418-z – volume: 368 start-page: 1326 year: 2013 ident: 524_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMsa1204629 – volume: 63 start-page: 56 year: 2018 ident: 524_CR37 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2017.06.007 – volume: 38 start-page: 1285 year: 1988 ident: 524_CR72 publication-title: Neurology doi: 10.1212/WNL.38.8.1285 – volume: 549 start-page: 523 year: 2017 ident: 524_CR170 publication-title: Nature doi: 10.1038/nature24016 – volume: 44 start-page: 9 issue: Suppl 1 year: 2017 ident: 524_CR51 publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.12758 – volume: 16 start-page: 675 year: 1996 ident: 524_CR271 publication-title: Neuron doi: 10.1016/S0896-6273(00)80086-0 – volume: 120 start-page: 483 year: 2005 ident: 524_CR111 publication-title: Cell doi: 10.1016/j.cell.2005.02.001 – volume: 664 start-page: 79 year: 2018 ident: 524_CR302 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2017.11.027 – volume: 372 start-page: 1371 year: 2021 ident: 524_CR291 publication-title: Science doi: 10.1126/science.abk0575 – volume: 33 start-page: 108271 year: 2020 ident: 524_CR75 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108271 – volume: 108 start-page: 876 year: 2020 ident: 524_CR265 publication-title: Neuron doi: 10.1016/j.neuron.2020.09.016 – volume: 19 start-page: 1073 year: 2016 ident: 524_CR267 publication-title: Nat Neurosci doi: 10.1038/nn.4340 – volume: 142 start-page: 104953 year: 2020 ident: 524_CR165 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2020.104953 – volume: 33 start-page: 331 year: 1989 ident: 524_CR94 publication-title: Surv Ophthalmol doi: 10.1016/0039-6257(89)90010-6 – volume: 70 start-page: 63 year: 2011 ident: 524_CR218 publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e31820376cc – volume: 54 start-page: 461 year: 1970 ident: 524_CR152 publication-title: Br J Ophthalmol doi: 10.1136/bjo.54.7.461 – volume: 195 start-page: 111438 year: 2021 ident: 524_CR258 publication-title: Mech Ageing Dev doi: 10.1016/j.mad.2021.111438 – volume: 20 start-page: 595 year: 2001 ident: 524_CR150 publication-title: Prog Retin Eye Res doi: 10.1016/S1350-9462(01)00005-2 – volume: 11 start-page: 102 year: 1976 ident: 524_CR88 publication-title: Can J Ophthalmol – volume: 43 start-page: 375 year: 2020 ident: 524_CR244 publication-title: Annu Rev Neurosci doi: 10.1146/annurev-neuro-070918-050154 – volume: 13 start-page: 2176 year: 2018 ident: 524_CR243 publication-title: Nat Protoc doi: 10.1038/s41596-018-0029-2 – volume: 10 start-page: 17359 year: 2020 ident: 524_CR282 publication-title: Sci Rep doi: 10.1038/s41598-020-71460-6 – volume: 56 start-page: 100804 year: 2020 ident: 524_CR176 publication-title: Front Neuroendocrinol doi: 10.1016/j.yfrne.2019.100804 – volume: 27 start-page: 954 year: 2021 ident: 524_CR196 publication-title: Nat Med doi: 10.1038/s41591-021-01382-x – volume: 1866 start-page: 158980 year: 2021 ident: 524_CR64 publication-title: Biochim Biophys Acta Mol Cell Biol Lipids doi: 10.1016/j.bbalip.2021.158980 – volume: 107 start-page: 436 year: 2020 ident: 524_CR242 publication-title: Neuron doi: 10.1016/j.neuron.2020.05.014 – ident: 524_CR27 doi: 10.1016/j.preteyeres.2021.100953 – volume: 45 start-page: 45 year: 2015 ident: 524_CR224 publication-title: J Alzheimers Dis doi: 10.3233/JAD-141659 – volume: 9 start-page: 1056 year: 2018 ident: 524_CR53 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01056 – volume: 58 start-page: 100850 year: 2020 ident: 524_CR177 publication-title: Front Neuroendocrinol doi: 10.1016/j.yfrne.2020.100850 – volume: 258 start-page: 882 year: 2011 ident: 524_CR213 publication-title: J Neurol doi: 10.1007/s00415-010-5863-2 – volume: 133 start-page: 19 year: 2015 ident: 524_CR33 publication-title: Exp Eye Res doi: 10.1016/j.exer.2015.02.011 – volume: 16 start-page: 585 year: 2017 ident: 524_CR47 publication-title: Aging Cell doi: 10.1111/acel.12589 – volume: 365 start-page: 223 year: 2019 ident: 524_CR11 publication-title: Science doi: 10.1126/science.aay2720 – volume: 8 start-page: e57557 year: 2013 ident: 524_CR96 publication-title: PLoS ONE doi: 10.1371/journal.pone.0057557 – volume: 16 start-page: 974 year: 2020 ident: 524_CR209 publication-title: Alzheimers Dement doi: 10.1002/alz.12097 – ident: 524_CR139 doi: 10.3389/fnene.2010.00005 – volume: 51 start-page: 207 year: 2010 ident: 524_CR232 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.09-3947 – volume: 39 start-page: 24 year: 2008 ident: 524_CR179 publication-title: Stroke doi: 10.1161/STROKEAHA.107.493262 – volume: 488 start-page: 96 year: 2012 ident: 524_CR297 publication-title: Nature doi: 10.1038/nature11283 – volume: 28 start-page: 9363 year: 2008 ident: 524_CR99 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1447-08.2008 – volume: 370 start-page: 61 year: 2020 ident: 524_CR164 publication-title: Science doi: 10.1126/science.abb8575 – volume: 287 start-page: 365 year: 2017 ident: 524_CR235 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2015.12.015 – volume: 42 start-page: 1499 year: 2020 ident: 524_CR10 publication-title: GeroScience doi: 10.1007/s11357-020-00252-7 – volume: 24 start-page: 16 issue: Suppl 1 year: 2021 ident: 524_CR191 publication-title: Vet Ophthalmol doi: 10.1111/vop.12858 – volume: 13 start-page: 340 year: 2004 ident: 524_CR158 publication-title: J Glaucoma doi: 10.1097/00061198-200408000-00013 – volume: 34 start-page: 674 year: 2021 ident: 524_CR40 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2020.8075 – volume: 75 start-page: 563 year: 2014 ident: 524_CR178 publication-title: Ann Neurol doi: 10.1002/ana.24135 – volume: 36 start-page: 432 year: 2018 ident: 524_CR250 publication-title: Nat Biotechnol doi: 10.1038/nbt.4127 – volume: 1698 start-page: 179 year: 2018 ident: 524_CR63 publication-title: Brain Res doi: 10.1016/j.brainres.2018.08.006 – volume: 61 start-page: 553 year: 2018 ident: 524_CR61 publication-title: J Alzheimers Dis doi: 10.3233/JAD-170777 – volume: 33 start-page: 1 year: 2015 ident: 524_CR17 publication-title: Neurol Clin doi: 10.1016/j.ncl.2014.09.010 – volume: 17 start-page: 265 year: 2021 ident: 524_CR54 publication-title: Nat Rev Neurol doi: 10.1038/s41582-021-00483-y – volume: 34 start-page: 11929 year: 2014 ident: 524_CR120 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1860-14.2014 – ident: 524_CR117 doi: 10.3390/biomedicines8120591 – volume: 11 start-page: 667 year: 2020 ident: 524_CR301 publication-title: Nat Commun doi: 10.1038/s41467-019-14279-8 – volume: 13 start-page: 521 year: 2019 ident: 524_CR140 publication-title: Front Neurosci doi: 10.3389/fnins.2019.00521 – volume: 585 start-page: 91 year: 2020 ident: 524_CR153 publication-title: Nature doi: 10.1038/s41586-020-2589-x – volume: 48 start-page: 370 year: 2017 ident: 524_CR67 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2017.08.002 – volume: 76 start-page: 791 year: 2019 ident: 524_CR210 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2019.0765 – volume: 30 start-page: 1350 year: 2009 ident: 524_CR62 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2007.11.014 – volume: 88 start-page: 799 year: 2009 ident: 524_CR29 publication-title: Exp Eye Res doi: 10.1016/j.exer.2009.02.003 – volume: 97 start-page: 70 year: 2019 ident: 524_CR76 publication-title: J Neurosci Res doi: 10.1002/jnr.24256 – volume: 82 start-page: 239 year: 1991 ident: 524_CR8 publication-title: Acta Neuropathol doi: 10.1007/BF00308809 – volume: 41 start-page: 1023 year: 2020 ident: 524_CR211 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2020.09.011 – volume: 11 start-page: 22 year: 2019 ident: 524_CR294 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-019-0479-y – volume: 85 start-page: 1244 year: 2015 ident: 524_CR281 publication-title: Neuron doi: 10.1016/j.neuron.2015.02.017 – volume: 42 start-page: 631 year: 1992 ident: 524_CR7 publication-title: Neurology doi: 10.1212/WNL.42.3.631 – volume: 1 start-page: fcz035 year: 2019 ident: 524_CR125 publication-title: Brain Commun doi: 10.1093/braincomms/fcz035 – volume: 26 start-page: 952 year: 2020 ident: 524_CR163 publication-title: Nat Med doi: 10.1038/s41591-020-0886-4 – volume: 54 start-page: 204-17 issue: Suppl 1 year: 2011 ident: 524_CR219 publication-title: NeuroImage – volume: 31 start-page: 107776 year: 2020 ident: 524_CR105 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.107776 – volume: 129 start-page: 281 year: 2020 ident: 524_CR167 publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2020.07.015 – ident: 524_CR238 doi: 10.3791/57122 – volume: 36 start-page: 186 year: 2017 ident: 524_CR129 publication-title: Mitochondrion doi: 10.1016/j.mito.2017.08.014 – volume: 61 start-page: 3 year: 2020 ident: 524_CR68 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.61.8.3 – volume: 23 start-page: 5838 year: 2014 ident: 524_CR257 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu277 – volume: 7 start-page: 10472 year: 2016 ident: 524_CR275 publication-title: Nat Commun doi: 10.1038/ncomms10472 – volume: 59 start-page: 182 year: 2006 ident: 524_CR65 publication-title: Ann Neurol doi: 10.1002/ana.20694 – volume: 314 start-page: 130 year: 2006 ident: 524_CR21 publication-title: Science doi: 10.1126/science.1134108 – volume: 125 start-page: e70 year: 2019 ident: 524_CR239 publication-title: Curr Protoc Immunol doi: 10.1002/cpim.70 – volume: 6 start-page: 37 year: 2014 ident: 524_CR230 publication-title: Alzheimers Res Ther doi: 10.1186/alzrt269 – volume: 9 start-page: 586 year: 2018 ident: 524_CR52 publication-title: Front Immunol doi: 10.3389/fimmu.2018.00586 – volume: 3 start-page: 136 year: 2015 ident: 524_CR55 publication-title: Ann Transl Med – volume: 9 start-page: 305 year: 2002 ident: 524_CR169 publication-title: Neurobiol Dis doi: 10.1006/nbdi.2002.0483 – volume: 26 start-page: 296 year: 2021 ident: 524_CR253 publication-title: Mol Psychiatry doi: 10.1038/s41380-020-0721-9 – volume: 10 start-page: 122 year: 2019 ident: 524_CR71 publication-title: Front Neurol doi: 10.3389/fneur.2019.00122 – volume: 5 start-page: 375 year: 2021 ident: 524_CR304 publication-title: J Alzheimers Dis Rep doi: 10.3233/ADR-210283 – ident: 524_CR148 doi: 10.7554/eLife.29595 – volume: 10 start-page: 9802 year: 2020 ident: 524_CR283 publication-title: Sci Rep doi: 10.1038/s41598-020-66092-9 – volume: 22 start-page: 269 year: 2018 ident: 524_CR49 publication-title: Cell Rep doi: 10.1016/j.celrep.2017.12.039 – volume: 127 start-page: 4403 year: 2017 ident: 524_CR305 publication-title: J Clin Invest doi: 10.1172/JCI77398 – volume: 8 start-page: e67094 year: 2013 ident: 524_CR80 publication-title: PLoS ONE doi: 10.1371/journal.pone.0067094 – volume: 9 start-page: 3209 year: 2018 ident: 524_CR98 publication-title: Nat Commun doi: 10.1038/s41467-018-05681-9 – ident: 524_CR276 doi: 10.3390/pharmaceutics13060865 – ident: 524_CR42 doi: 10.3390/biomedicines9050524 – volume: 15 start-page: 639140 year: 2021 ident: 524_CR141 publication-title: Front Neurosci doi: 10.3389/fnins.2021.639140 – volume: 23 start-page: 2284 year: 2003 ident: 524_CR100 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-06-02284.2003 – volume: 94 start-page: 52 year: 2017 ident: 524_CR14 publication-title: Exp Gerontol doi: 10.1016/j.exger.2016.11.004 – volume: 97 start-page: e331 year: 2019 ident: 524_CR234 publication-title: Acta Ophthalmol doi: 10.1111/aos.13983 – volume: 112 start-page: 2581 year: 2015 ident: 524_CR270 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1423221112 – volume: 392 start-page: 605 year: 1998 ident: 524_CR115 publication-title: Nature doi: 10.1038/33416 – volume: 115 start-page: E1896 year: 2018 ident: 524_CR48 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1800165115 – volume: 81 start-page: 100880 year: 2021 ident: 524_CR236 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2020.100880 – volume: 15 start-page: 235 year: 2020 ident: 524_CR108 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathmechdis-012419-032711 – volume: 248 start-page: 118 year: 2019 ident: 524_CR277 publication-title: Dev Dyn doi: 10.1002/dvdy.24672 – volume: 7 start-page: 41 year: 2006 ident: 524_CR142 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1824 – ident: 524_CR251 – volume: 64 start-page: 523 year: 2001 ident: 524_CR85 publication-title: J Neurosci Res doi: 10.1002/jnr.1104 – ident: 524_CR285 doi: 10.1101/2021.10.21.465277 – volume: 75 start-page: 100799 year: 2020 ident: 524_CR233 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2019.100799 – volume: 84 start-page: 10 year: 2018 ident: 524_CR13 publication-title: Ann Neurol doi: 10.1002/ana.25246 – volume: 43 start-page: 27 issue: Suppl 1 year: 1999 ident: 524_CR149 publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(99)00018-1 – volume: 54 start-page: 485 year: 2006 ident: 524_CR183 publication-title: Glia doi: 10.1002/glia.20404 – ident: 524_CR173 doi: 10.1126/scitranslmed.aay1809 – ident: 524_CR187 doi: 10.1007/s10571-020-00965-5 – volume: 368 start-page: 107 year: 2013 ident: 524_CR256 publication-title: N Engl J Med doi: 10.1056/NEJMoa1211103 – volume: 368 start-page: 117 year: 2013 ident: 524_CR255 publication-title: N Engl J Med doi: 10.1056/NEJMoa1211851 – volume: 108 start-page: 801 year: 2020 ident: 524_CR59 publication-title: Neuron doi: 10.1016/j.neuron.2020.09.029 – volume: 8 start-page: 452 year: 2020 ident: 524_CR32 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00452 – volume: 31 start-page: 280 year: 1994 ident: 524_CR132 publication-title: J Med Genet doi: 10.1136/jmg.31.4.280 – volume: 250 start-page: 589 year: 2012 ident: 524_CR159 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-011-1842-2 – volume: 113 start-page: E1738-46 year: 2016 ident: 524_CR240 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1525528113 – volume: 11 start-page: 3753 year: 2020 ident: 524_CR70 publication-title: Nat Commun doi: 10.1038/s41467-020-17514-9 – volume: 6 start-page: 195 year: 2020 ident: 524_CR254 publication-title: Annu Rev Vis Sci doi: 10.1146/annurev-vision-022720-094953 – volume: 11 start-page: 710 year: 2015 ident: 524_CR147 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2014.10.008 – volume: 24 start-page: 621 year: 1980 ident: 524_CR25 publication-title: Surv Ophthalmol doi: 10.1016/0039-6257(80)90123-X – volume: 16 start-page: 149 year: 2021 ident: 524_CR278 publication-title: Stem Cell Reports doi: 10.1016/j.stemcr.2020.12.001 – volume: 480 start-page: 69 year: 2010 ident: 524_CR222 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2010.06.006 – volume: 8 start-page: 361 year: 2011 ident: 524_CR146 publication-title: Neurotherapeutics doi: 10.1007/s13311-011-0047-z – volume: 588 start-page: 459 year: 2020 ident: 524_CR273 publication-title: Nature doi: 10.1038/s41586-020-2709-7 – volume: 353 start-page: 339 year: 2013 ident: 524_CR81 publication-title: Cell Tissue Res doi: 10.1007/s00441-013-1666-y – volume: 11 start-page: 65 year: 2020 ident: 524_CR86 publication-title: Front Immunol doi: 10.3389/fimmu.2020.00065 – volume: 10 start-page: e0134750 year: 2015 ident: 524_CR225 publication-title: PLoS ONE doi: 10.1371/journal.pone.0134750 – volume: 8 start-page: 669846 year: 2021 ident: 524_CR39 publication-title: Front Nutr doi: 10.3389/fnut.2021.669846 – volume: 68 start-page: 895 year: 2001 ident: 524_CR116 publication-title: Am J Hum Genet doi: 10.1086/319522 – ident: 524_CR113 doi: 10.1083/jcb.202102136 – ident: 524_CR18 doi: 10.1016/j.nicl.2021.102718 – volume: 10 start-page: 65 year: 2020 ident: 524_CR203 publication-title: EJNMMI Res doi: 10.1186/s13550-020-00653-x – volume: 16 start-page: 199 year: 2020 ident: 524_CR221 publication-title: Nat Rev Neurol doi: 10.1038/s41582-020-0333-7 – volume: 144 start-page: 3698 year: 2017 ident: 524_CR248 publication-title: Development doi: 10.1242/dev.146290 – volume: 35 start-page: 2230 year: 2020 ident: 524_CR206 publication-title: Mov Disord doi: 10.1002/mds.28242 – volume: 12 start-page: 651639 year: 2021 ident: 524_CR133 publication-title: Front Neurol doi: 10.3389/fneur.2021.651639 – volume: 12 start-page: 1383 year: 1980 ident: 524_CR24 publication-title: Ann Ophthalmol – volume: 35 start-page: 13568 year: 2015 ident: 524_CR69 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2468-15.2015 – volume: 23 start-page: 2322 year: 2013 ident: 524_CR175 publication-title: Cereb Cortex doi: 10.1093/cercor/bhs222 – volume: 283 start-page: 29615 year: 2008 ident: 524_CR9 publication-title: J Biol Chem doi: 10.1074/jbc.R800019200 – volume: 97 start-page: 284 year: 1979 ident: 524_CR92 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1979.01020010136007 – volume: 13 start-page: eabc9375 year: 2021 ident: 524_CR300 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abc9375 – volume: 15 start-page: 673 year: 2016 ident: 524_CR199 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(16)00070-3 – volume: 908 start-page: 244 year: 2000 ident: 524_CR46 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2000.tb06651.x – volume: 54 start-page: 211 year: 2021 ident: 524_CR45 publication-title: Immunity doi: 10.1016/j.immuni.2021.01.013 – volume: 106 start-page: 19587 year: 2009 ident: 524_CR102 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0907085106 – volume: 117 start-page: 1050 year: 1999 ident: 524_CR84 publication-title: Arch Ophthalmol doi: 10.1001/archopht.117.8.1050 – volume: 121 start-page: 2081 year: 2014 ident: 524_CR23 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.05.013 – volume: 14 start-page: 1398 year: 2011 ident: 524_CR137 publication-title: Nat Neurosci doi: 10.1038/nn.2946 – ident: 524_CR22 – volume: 7 start-page: 263 year: 2011 ident: 524_CR4 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2011.03.005 – volume: 28 start-page: 12085 year: 2008 ident: 524_CR97 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3200-08.2008 – volume: 46 start-page: 329 year: 2021 ident: 524_CR118 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2020.11.007 – volume: 361 start-page: 109281 year: 2021 ident: 524_CR197 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2021.109281 – ident: 524_CR144 doi: 10.1126/scitranslmed.aaw3210 – ident: 524_CR34 doi: 10.3390/cells10050994 – volume: 15 start-page: 565 year: 2019 ident: 524_CR38 publication-title: Nat Rev Neurol doi: 10.1038/s41582-019-0244-7 – volume: 82 start-page: 128 year: 2017 ident: 524_CR298 publication-title: Ann Neurol doi: 10.1002/ana.24969 – volume: 136 start-page: 2697 year: 2013 ident: 524_CR12 publication-title: Brain doi: 10.1093/brain/awt188 – volume: 257 start-page: 1963 year: 2019 ident: 524_CR93 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-019-04382-3 – volume: 10 start-page: 203 year: 2018 ident: 524_CR87 publication-title: Front Aging Neurosci doi: 10.3389/fnagi.2018.00203 – volume: 117 start-page: 18810 year: 2020 ident: 524_CR106 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2009425117 – volume: 34 start-page: 29 year: 2020 ident: 524_CR189 publication-title: Eye (Lond) doi: 10.1038/s41433-019-0632-7 – volume: 75 start-page: 964 year: 2014 ident: 524_CR220 publication-title: Ann Neurol doi: 10.1002/ana.24182 – volume: 136 start-page: 1242 year: 2018 ident: 524_CR227 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2018.3556 – volume: 13 start-page: 625 year: 1998 ident: 524_CR182 publication-title: Int J Geriatr Psychiatry doi: 10.1002/(SICI)1099-1166(199809)13:9<625::AID-GPS835>3.0.CO;2-2 – volume: 14 start-page: 483 year: 2013 ident: 524_CR259 publication-title: Nat Rev Genet doi: 10.1038/nrg3461 – volume: 89 start-page: e544-9 year: 2011 ident: 524_CR90 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2011.02175.x – volume: 15 start-page: e1002487 year: 2018 ident: 524_CR260 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002487 – ident: 524_CR162 doi: 10.1073/pnas.2110329119 – volume: 16 start-page: 49 year: 2021 ident: 524_CR262 publication-title: Mol Neurodegeneration doi: 10.1186/s13024-021-00467-y – volume: 23 start-page: 1183 year: 2020 ident: 524_CR303 publication-title: Nat Neurosci doi: 10.1038/s41593-020-0687-6 – ident: 524_CR190 doi: 10.3390/biom11040581 – volume: 102 start-page: 233 year: 2018 ident: 524_CR226 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2017-310476 – volume: 8 start-page: e1000298 year: 2010 ident: 524_CR114 publication-title: PLoS Biol doi: 10.1371/journal.pbio.1000298 – volume: 36 start-page: 9148 year: 2016 ident: 524_CR264 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1747-16.2016 – volume: 13 start-page: e14781 year: 2021 ident: 524_CR292 publication-title: EMBO Mol Med doi: 10.15252/emmm.202114781 – volume: 16 start-page: 2 year: 2021 ident: 524_CR287 publication-title: Mol Neurodegener doi: 10.1186/s13024-021-00424-9 – volume: 6 start-page: 91 year: 2020 ident: 524_CR245 publication-title: Annu Rev Vis Sci doi: 10.1146/annurev-vision-121219-081855 – volume: 3 start-page: 17013 year: 2017 ident: 524_CR16 publication-title: Nat Rev Dis Primers doi: 10.1038/nrdp.2017.13 – volume: 42 start-page: 26 year: 2020 ident: 524_CR188 publication-title: The Biochemist doi: 10.1042/BIO20200063 – volume: 25 start-page: 1680 year: 2019 ident: 524_CR299 publication-title: Nat Med doi: 10.1038/s41591-019-0611-3 – volume: 54 start-page: 5953 year: 2013 ident: 524_CR223 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-12046 – volume: 87 start-page: 329 year: 2020 ident: 524_CR208 publication-title: Ann Neurol doi: 10.1002/ana.25682 – volume: 235 start-page: 618 year: 1997 ident: 524_CR157 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/BF00946937 – volume: 26 start-page: 1256 year: 2020 ident: 524_CR5 publication-title: Nat Med doi: 10.1038/s41591-020-0938-9 – volume: 537 start-page: 50 year: 2016 ident: 524_CR289 publication-title: Nature doi: 10.1038/nature19323 – volume: 12 start-page: 643254 year: 2021 ident: 524_CR44 publication-title: Front Pharmacol doi: 10.3389/fphar.2021.643254 – volume: 7 start-page: 22 year: 2019 ident: 524_CR166 publication-title: Curr Genetic Med Rep doi: 10.1007/s40142-019-0158-0 – ident: 524_CR241 doi: 10.1101/2021.07.15.452509 – volume: 14 start-page: 1227 year: 2011 ident: 524_CR58 publication-title: Nat Neurosci doi: 10.1038/nn.2923 – volume: 8 start-page: 328 year: 2020 ident: 524_CR228 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00328 – ident: 524_CR2 – volume: 590 start-page: 473 year: 2021 ident: 524_CR274 publication-title: Nature doi: 10.1038/s41586-020-03116-4 – volume: 160 start-page: 177 year: 2015 ident: 524_CR112 publication-title: Cell doi: 10.1016/j.cell.2014.12.019 – volume: 183 start-page: 1699 year: 2020 ident: 524_CR204 publication-title: Cell doi: 10.1016/j.cell.2020.10.029 – volume: 93 start-page: 187 year: 2011 ident: 524_CR95 publication-title: Exp Eye Res doi: 10.1016/j.exer.2010.08.016 – volume: 172 start-page: 257 year: 2001 ident: 524_CR268 publication-title: Exp Neurol doi: 10.1006/exnr.2001.7822 – volume: 138 start-page: 1 year: 2004 ident: 524_CR26 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2004.04.045 – volume: 254 start-page: 1178 year: 1991 ident: 524_CR214 publication-title: Science doi: 10.1126/science.1957169 – volume: 374 start-page: n1682 year: 2021 ident: 524_CR288 publication-title: BMJ doi: 10.1136/bmj.n1682 – volume: 112 start-page: 10515 year: 2015 ident: 524_CR127 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1509879112 – volume: 519 start-page: 599 year: 2011 ident: 524_CR78 publication-title: J Comp Neurol doi: 10.1002/cne.22516 – volume: 13 start-page: 982 year: 2017 ident: 524_CR124 publication-title: Autophagy doi: 10.1080/15548627.2017.1291114 – volume: 27 start-page: 1706 year: 1986 ident: 524_CR156 publication-title: Invest Ophthalmol Vis Sci – volume: 53 start-page: 473 year: 2020 ident: 524_CR284 publication-title: Dev Cell doi: 10.1016/j.devcel.2020.04.009 – volume: 93 start-page: 120 year: 2011 ident: 524_CR28 publication-title: Exp Eye Res doi: 10.1016/j.exer.2010.09.005 – volume: 31 start-page: 140 year: 2016 ident: 524_CR186 publication-title: Semin Ophthalmol doi: 10.3109/08820538.2015.1114845 – volume: 9 start-page: 843 year: 2006 ident: 524_CR101 publication-title: Nat Neurosci doi: 10.1038/nn1701 – volume: 541 start-page: 481 year: 2017 ident: 524_CR104 publication-title: Nature doi: 10.1038/nature21029 – ident: 524_CR201 doi: 10.1001/jamaneurol.2021.3180 – volume: 157 start-page: 20 year: 2017 ident: 524_CR41 publication-title: Exp Eye Res doi: 10.1016/j.exer.2017.02.014 – volume: 97 start-page: 18 year: 2019 ident: 524_CR202 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2018.12.001 – volume: 53 start-page: 721 year: 1969 ident: 524_CR151 publication-title: Br J Ophthalmol doi: 10.1136/bjo.53.11.721 – volume: 7 start-page: 1661 year: 2020 ident: 524_CR207 publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.51158 – volume: 14 start-page: 577 year: 2020 ident: 524_CR119 publication-title: Front Neurosci doi: 10.3389/fnins.2020.00577 – volume: 468 start-page: 232 year: 2010 ident: 524_CR138 publication-title: Nature doi: 10.1038/nature09613 – volume: 30 start-page: 15654 year: 2010 ident: 524_CR103 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4340-10.2010 – volume: 355 start-page: 756 year: 2017 ident: 524_CR126 publication-title: Science doi: 10.1126/science.aal0092 – volume: 104 start-page: 1039 year: 2019 ident: 524_CR280 publication-title: Neuron doi: 10.1016/j.neuron.2019.11.006 – volume: 121 start-page: 1429 year: 2011 ident: 524_CR79 publication-title: J Clin Invest doi: 10.1172/JCI44646 – volume: 80 start-page: 100875 year: 2021 ident: 524_CR194 publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2020.100875 – volume: 17 start-page: 157 year: 2021 ident: 524_CR3 publication-title: Nat Rev Neurol doi: 10.1038/s41582-020-00435-y – volume: 24 start-page: 1044 year: 2003 ident: 524_CR73 publication-title: Zhonghua Liu Xing Bing Xue Za Zhi – ident: 524_CR43 doi: 10.3390/ijms22094956 – ident: 524_CR215 doi: 10.3390/cells7060060 – volume: 109 start-page: 1657 year: 2021 ident: 524_CR171 publication-title: Neuron doi: 10.1016/j.neuron.2021.03.024 – ident: 524_CR172 doi: 10.1126/scitranslmed.aay3069 – volume: 86 start-page: 1000 year: 2015 ident: 524_CR266 publication-title: Neuron doi: 10.1016/j.neuron.2015.03.060 – volume: 71 start-page: 799 year: 2011 ident: 524_CR237 publication-title: Neuron doi: 10.1016/j.neuron.2011.07.022 – volume: 12 start-page: 49 year: 2020 ident: 524_CR198 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-020-00612-7 – volume: 31 start-page: 1508 year: 2017 ident: 524_CR66 publication-title: FASEB J doi: 10.1096/fj.201601084R – volume: 15 start-page: 30 year: 2020 ident: 524_CR122 publication-title: Mol Neurodegener doi: 10.1186/s13024-020-00376-6 – volume: 701 start-page: 108815 year: 2021 ident: 524_CR128 publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2021.108815 – volume: 80 start-page: 696 year: 1968 ident: 524_CR161 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1968.00980050698002 – volume: 335 start-page: 108623 year: 2020 ident: 524_CR263 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2020.108623 – volume: 594 start-page: 309 year: 2021 ident: 524_CR290 publication-title: Nature doi: 10.1038/d41586-021-01546-2 – volume: 34 start-page: 1065 year: 2009 ident: 524_CR180 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.02.009 – volume: 9 start-page: 1287 year: 2018 ident: 524_CR130 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01287 – volume: 153 start-page: 1194 year: 2013 ident: 524_CR50 publication-title: Cell doi: 10.1016/j.cell.2013.05.039 – volume: 108 start-page: 10190 year: 2011 ident: 524_CR109 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1107402108 – ident: 524_CR231 doi: 10.3390/cells9112415 – volume: 18 start-page: 123 year: 2017 ident: 524_CR143 publication-title: Nat Immunol doi: 10.1038/ni.3666 – volume: 103 start-page: 263 year: 2019 ident: 524_CR286 publication-title: Med Clin North Am doi: 10.1016/j.mcna.2018.10.009 – volume: 46 start-page: 1721 year: 2005 ident: 524_CR155 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1347 – volume: 20 start-page: 4615 year: 2000 ident: 524_CR269 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-12-04615.2000 – volume: 173 start-page: 353 year: 2008 ident: 524_CR160 publication-title: Prog Brain Res doi: 10.1016/S0079-6123(08)01125-4 – volume: 342 start-page: 697 year: 1993 ident: 524_CR60 publication-title: Lancet doi: 10.1016/0140-6736(93)91705-Q – volume: 103 start-page: 1014 year: 1996 ident: 524_CR89 publication-title: Ophthalmology doi: 10.1016/S0161-6420(96)30572-1 – volume: 5 start-page: 347 year: 2004 ident: 524_CR136 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1387 – volume: 12 start-page: 60 year: 2016 ident: 524_CR229 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2015.12.003 – volume: 5 start-page: 4047 year: 2014 ident: 524_CR247 publication-title: Nat Commun doi: 10.1038/ncomms5047 – volume: 4 start-page: 575 year: 2018 ident: 524_CR56 publication-title: Alzheimers Dement (N Y) doi: 10.1016/j.trci.2018.06.014 – volume: 96 start-page: 17 year: 2017 ident: 524_CR135 publication-title: Neuron doi: 10.1016/j.neuron.2017.07.030 – volume: 2021 start-page: 4581909 year: 2021 ident: 524_CR107 publication-title: J Ophthalmol doi: 10.1155/2021/4581909 – volume: 69 start-page: 89 year: 2001 ident: 524_CR195 publication-title: Clin Pharmacol Ther doi: 10.1067/mcp.2001.113989 – volume: 171 start-page: 1001 year: 2005 ident: 524_CR272 publication-title: J Cell Biol doi: 10.1083/jcb.200508072 – volume: 20 start-page: 145 year: 2021 ident: 524_CR252 publication-title: Nat Mater doi: 10.1038/s41563-020-00804-4 – volume: 60 start-page: 26 year: 2019 ident: 524_CR36 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.18-25837 – volume: 63 start-page: 296 year: 2018 ident: 524_CR31 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2017.09.010 – volume: 4 start-page: 175 year: 2020 ident: 524_CR57 publication-title: J Alzheimers Dis Rep doi: 10.3233/ADR-200171 – volume: 191 start-page: 107900 year: 2020 ident: 524_CR35 publication-title: Exp Eye Res doi: 10.1016/j.exer.2019.107900 – ident: 524_CR279 doi: 10.3390/cells9081759 – volume: 71 start-page: 44 year: 2014 ident: 524_CR82 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2014.07.016 – volume: 76 start-page: 537 year: 1999 ident: 524_CR193 publication-title: Optom Vis Sci doi: 10.1097/00006324-199908000-00022 – volume: 89 start-page: 37 year: 2016 ident: 524_CR121 publication-title: Neuron doi: 10.1016/j.neuron.2015.11.013 – ident: 524_CR19 doi: 10.1101/cshperspect.a009258 – volume: 196 start-page: 111473 year: 2021 ident: 524_CR174 publication-title: Mech Ageing Dev doi: 10.1016/j.mad.2021.111473 – volume: 16 start-page: 29 year: 2021 ident: 524_CR293 publication-title: Mol Neurodegeneration doi: 10.1186/s13024-021-00452-5 – volume: 44 start-page: 5309 year: 2003 ident: 524_CR154 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.03-0587 – volume: 184 start-page: 4547 year: 2021 ident: 524_CR246 publication-title: Cell doi: 10.1016/j.cell.2021.07.003 – ident: 524_CR110 doi: 10.3390/biology8020031 – volume: 157 start-page: 5 year: 2017 ident: 524_CR30 publication-title: Exp Eye Res doi: 10.1016/j.exer.2017.02.006 – ident: 524_CR205 doi: 10.1001/jamaneurol.2020.3311 – ident: 524_CR216 doi: 10.1016/j.preteyeres.2021.100976 – volume: 60 start-page: 1495 year: 2003 ident: 524_CR6 publication-title: Neurology doi: 10.1212/01.WNL.0000063311.58879.01 – volume: 16 start-page: 46 year: 2019 ident: 524_CR212 publication-title: J Neuroinflammation doi: 10.1186/s12974-019-1399-2 |
SSID | ssj0047005 |
Score | 2.6419196 |
SecondaryResourceType | review_article |
Snippet | Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of... Abstract Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration,... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 23 |
SubjectTerms | Age Alzheimer's disease Amyotrophic lateral sclerosis Bioenergetics Biomechanics Blindness Brain research Care and treatment Central nervous system Cognitive ability Dementia Development and progression Etiology Extracellular matrix Fatalities Genetics Glaucoma Glaucoma - pathology Health aspects Humans Huntington’s Disease Inflammation Metabolism Nervous system Nervous system diseases Neurodegeneration Neurodegenerative diseases Neurodegenerative Diseases - pathology Neurodegenerative Diseases - therapy Neurons Neuroprotection Optic nerve Optic Nerve - pathology Parkinson's disease Pathogenesis Pathophysiology Protection and preservation Proteins Regeneration Review Therapeutic targets |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SkxdR68dqWyKIHmTpbj43vT2LpQj2ooXewuZLC337xH1F_O87k_3gLQW9eFs2CSSTmcz8kskvhLz1nsvQCFOq1IRSMKfKVjOwqyCT8SoBbsb7zl8u1Pml-Hwlr3ae-sKcsIEeeBDcscdzIcNCcAywgJatCZVqfC1jHWXI7wsz8HkTmBrWYKFBuaYrMo067vF4TpSYuY77oPC1cEOZrf_-mrzjlJYJkzse6OwxeTSGjnQ1dPkJeRC7p2R_1QFsXv-h72hO5sy75Pvk4uvmBrcKaOarDPF7ZpfGSTihoGOge3Qd8dLvdb_uadsF2m8n0ggKcSy0-03nJPT-Gbk8-_Tt9Lwcn04ovVR8WzruKuZdk6okY-Smco0TPgpZidolxVoHwgsRrJkDQkoxpuAdeHYeQKqN9vw52es2XXxJqBEQVNVBJ9FqEbwCfNQmiFJU9FJDu4LUkyStH3nF8XmLG5vxRaPsIH0L0rdZ-rYqyIe5zc-BVeOvtT_iBM01kRE7_wA9saOe2H_pSUHe4_RatFvonm_H6wcwSGTAsisFkTCAv7ouyMGiJtibXxZPCmJHe-8tUwDoMzdgQd7MxdgSc9i6uLnFOkgUZAADFuTFoE_zkDgshdxIGKpeaNpizMuS7vpHZgOHgFNqI1_9DyG9Jg9ZNhJesvqA7G1_3cZDCLq27ijb1x2pUChn priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZteumltEkfbh6oUNpDMbH1tHsJ29IQCs2lDexNWK80kLWTeEPov--M1nZjCrktKwk80sxovtHoEyHvnePSV6LOVax8LphVeaMZ2JWXsXYqAm7G-84_TtXJmfi-lMsh4dYPZZWjT0yO2ncOc-SHTAFkSuxrR1fXOb4ahaerwxMaj8kTpC7Dki69nACX0KBi40WZSh32eEgncqxfx2wo_JptRomz_3_PfG9rmpdN3tuHjp-TZ0MASRebFX9BHoV2m-wsWgDPqz_0A00lnSlXvkNOf3aXmDCgibXSh_PEMY1L8ZmC1CASXQW8-nvRr3ratJ7265E6gkI0C-Pu6FSK3r8kZ8fffn09yYcHFHInFV_nltuCOVvFIsoQeF3YygoXhCxEaaNijQ0S3BvYNAecFEOI3lnY37kvg6y046_IVtu14Q2htYDQqvQ6ikYL7xSgpCZCrKKCkxrGZaQcZ9K4gV0cH7m4NAllVMpsZt_A7Js0-6bIyKdpzNWGW-PB3l9wgaaeyIud_uhuzs1gZsbhKWLNvLcMkKOWTe0LVblSBpDIlywjH3F5DVovfJ5rhksIICTyYJmFgngYIGBZZmRv1hOszs2bRwUxg9X35p-OZuTd1IwjsZKtDd0t9kG6oBqQYEZeb_RpEomDQ-S1BFH1TNNmMs9b2ovfiRMcwk6pa_n24c_aJU9ZUn-es3KPbK1vbsM-BFVre5As5y8EZCC2 priority: 102 providerName: ProQuest |
Title | Solving neurodegeneration: common mechanisms and strategies for new treatments |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35313950 https://www.proquest.com/docview/2652318677 https://www.proquest.com/docview/2641859217 https://pubmed.ncbi.nlm.nih.gov/PMC8935795 https://doaj.org/article/c304792ddb214075a9d068c15e1e5d12 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxQxFD708uKLqPUyWpcIog8yOpdcZgSRrbSUhS5iXdi3MLm1hd1Z3dmi_feeZGeGDhbBpx02yTA5OSfnfMnJF4DXWufMFLSMuStMTDPF40pkaFeGuVJzh7jZn3c-m_LTGZ3M2XwHuuuOWgE2d0I7f5_UbL14__vnzWc0-E_B4Av-ofGbbzT2eel-lROfdmEfPZPwhnpG-10FKpKQ0ogeM4kRhfHuEM2d7xg4qsDn__esfcttDVMqb_mokwdwvw0uyXirDQ9hx9aP4GBcI7Be3pA3JKR7hnX0A5ierxZ-MYEERktjLwL_tB-mjwS1ELWTLK0_FnzVLBtS1YY0m45WgmCki-1-kT5NvXkMs5Pj719O4_ZyhVgznm9ilask06pwiWPW5mWiCkW1pSyhqXI8q5RlOPWhveeIoZy1zmiFvj83qWWF0PkT2KtXtX0GpKQYdqVGOFoJajRHBFU5jGO41UxguwjSTpJSt8zj_gKMhQwIpOByK32J0pdB-jKJ4F3f5seWd-OftY_8APU1PWd2-GO1vpCtCUrtdxjLzBiVIaoUrCpNwgudMos9MmkWwVs_vNLrGn6ertoDCthJz5ElxxxjZYSHaRrB4aAmWqQeFncKIjuFlhlHyB_YAyN41Rf7lj7Lrbara1_HUwmViBIjeLrVp75LOU6Wecmwq2KgaYM-D0vqq8vAF44hKRMle_5fIn0B97JgDXmcpYewt1lf25cYf23UCHbFXIxgfzyenE_w9-h4-vXbKKxmjILB_QHHIy5N |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuCCiPQAEj8TigqBvHdhIkhLbQqqXtCkEr9WbiR0qlbrY0W1X9U_xGZrzJ0gipt96i2I7i8bw-e2YM8NraVLpcFLGqchcLblRcZhzlysmqsKpC3Ez5zntjtXUgvh7KwyX40-XCUFhlpxODonZTS3vka1whZArV1z6d_o7p1ig6Xe2u0JizxY6_vEDI1nzc_oLr-4bzzY39z1txe6tAbKVKZ7FJzZBbk1fDSnqPkN_kRlgv5FAkplK8NF6izCOjpwgeKu8rZw0avdQlXuaZTfG7t2BZpAhlBrC8vjH-9r3T_SJDpu5Sc3K11tCxoIgpYp72X_GpZ_7CLQH_24IrxrAfqHnF8m3eg7uty8pGcx67D0u-fgAroxrh-uSSvWUhiDTszq_A-Mf0hLYoWKiT6fxRqGpNi_-BIZ2RiGziKdn4uJk0rKwda2ZdsQqG_jOOu2CL4PfmIRzcCHEfwaCe1v4JsEKgM5e4rBJlJpxViMvKCr0j5a3McFwESUdJbdt65nStxokOuCZXek59jdTXgfp6GMH7xZjTeTWPa3uv0wItelIl7vBienakW8HWls4tC-6c4YhVM1kWbqhym0iPM3IJj-AdLa8mfYG_Z8s27QEnSZW39EihB46gM0kiWO31RDm3_eaOQXSrZxr9TyoieLVoppEUO1f76Tn1oQJFBWLPCB7P-WkxpRRVcFpInGrW47TenPst9fGvUIUcHV2ZFfLp9b_1Em5v7e_t6t3t8c4zuMODKKQxT1ZhMDs798_RpZuZF60cMfh506L7Fx_dYOE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Solving+neurodegeneration%3A+common+mechanisms+and+strategies+for+new+treatments&rft.jtitle=Molecular+neurodegeneration&rft.au=Wareham%2C+Lauren+K.&rft.au=Liddelow%2C+Shane+A.&rft.au=Temple%2C+Sally&rft.au=Benowitz%2C+Larry+I.&rft.date=2022-03-21&rft.issn=1750-1326&rft.eissn=1750-1326&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13024-022-00524-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13024_022_00524_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1326&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1326&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1326&client=summon |